Poly Cystic Ovary Syndrome Clinical Trial
Official title:
Effect of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is one of the most prevalent disorders worldwide. Insulin resistance, inflammation and disturbance in sex hormone levels are the main contributing factors of this disease.The majority of studies addressing the status of chronic low-grade inflammation in PCOS have focused on the measurement of C-reactive protein (CRP) followed by stimulation of interleukin 6 (IL-6) and tumor necrosis factor (TNF-alpha). Daflon 500 mg tablets (containing 90% of diosmin and 10% of hesperidin) is used in patients to treat varicose veins, venous ulcers, hemorrhoids and lymphatic insufficiency. It has anti-diabetic, anti-inflammatory, microcirculatory, and antioxidant effects. So the aim of the work is to investigate the effect of Diosmin/Hesperidin in the management of PCOS through evaluation of Oxidative stress and inflammation, improvement of signs and symptoms through patients' follow-up, improvement of PCOS status by sonography and hormonal levels, measuring of anti-diabetic effect by measuring, fasting insulin, HOMA-IR and measuring the improvement of patient's quality of life by using the women health questionnaire (WHQ).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02789488 -
Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome
|
Phase 4 | |
| Recruiting |
NCT06142656 -
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome
|
Phase 2/Phase 3 | |
| Completed |
NCT03713138 -
Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome
|
N/A |